Clioquinol for Otomycosis: A Lesser Understood Antimicrobial
- PMID: 31834186
- DOI: 10.1097/MAO.0000000000002513
Clioquinol for Otomycosis: A Lesser Understood Antimicrobial
Comment in
-
Response to Letter of Nevio Cimolai.Otol Neurotol. 2020 Jan;41(1):142. doi: 10.1097/MAO.0000000000002514. Otol Neurotol. 2020. PMID: 31834187 No abstract available.
Comment on
-
Necrotizing Otitis Externa-Analysis of 83 Cases: Clinical Findings and Course of Disease.Otol Neurotol. 2019 Jan;40(1):56-62. doi: 10.1097/MAO.0000000000001986. Otol Neurotol. 2019. PMID: 30239427
References
-
- Peled C, El-Seid S, Bahat-Dinur A, Tzvi-Ran LR, Kraus M, Kaplan D. Necrotizing otitis externa – analysis of 83 cases: clinical findings and course of disease. Otol Neurotol 2019; 40:56–62.
-
- Neldner KH. The halogenated 8-hydroxyquinolines. Int J Dermatol 1977; 16:267–273.
-
- Degen PH, Moppert J, Schmid K, et al. Percutaneous absorption of clioquinol (Vioform®). Dermatologica 1979; 159:295–301.
-
- EditorialClioquinol and other halogenated hydroxyquinolines. Lancet 1968; 1:679.
-
- Regös J, Zak O, Solf R, et al. Antimicrobial spectrum of triclosan, a broad-spectrum antimicrobial agent for topical application. II. Comparison with some other antimicrobial agents. Dermatologica 1979; 158:72–79.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
